Merit Medical Systems EPS - Earnings per Share 2010-2023 | MMSI
Merit Medical Systems eps - earnings per share from 2010 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Merit Medical Systems Annual EPS |
2023 |
$1.62 |
2022 |
$1.29 |
2021 |
$0.84 |
2020 |
$-0.18 |
2019 |
$0.10 |
2018 |
$0.78 |
2017 |
$0.55 |
2016 |
$0.45 |
2015 |
$0.53 |
2014 |
$0.53 |
2013 |
$0.39 |
2012 |
$0.46 |
2011 |
$0.58 |
2010 |
$0.35 |
2009 |
$0.63 |
Merit Medical Systems Quarterly EPS |
2023-12-31 |
$0.47 |
2023-09-30 |
$0.44 |
2023-06-30 |
$0.35 |
2023-03-31 |
$0.36 |
2022-12-31 |
$0.57 |
2022-09-30 |
$0.27 |
2022-06-30 |
$0.27 |
2022-03-31 |
$0.18 |
2021-12-31 |
$0.35 |
2021-09-30 |
$0.21 |
2021-06-30 |
$0.09 |
2021-03-31 |
$0.19 |
2020-12-31 |
$0.27 |
2020-09-30 |
$-0.05 |
2020-06-30 |
$-0.34 |
2020-03-31 |
$-0.06 |
2019-12-31 |
$-0.07 |
2019-09-30 |
$-0.06 |
2019-06-30 |
$0.12 |
2019-03-31 |
$0.11 |
2018-12-31 |
$0.17 |
2018-09-30 |
$0.30 |
2018-06-30 |
$0.21 |
2018-03-31 |
$0.10 |
2017-12-31 |
$0.11 |
2017-09-30 |
$-0.07 |
2017-06-30 |
$0.19 |
2017-03-31 |
$0.32 |
2016-12-31 |
$0.17 |
2016-09-30 |
$0.02 |
2016-06-30 |
$0.16 |
2016-03-31 |
$0.10 |
2015-12-31 |
$0.13 |
2015-09-30 |
$0.11 |
2015-06-30 |
$0.17 |
2015-03-31 |
$0.12 |
2014-12-31 |
$0.19 |
2014-09-30 |
$0.18 |
2014-06-30 |
$0.09 |
2014-03-31 |
$0.07 |
2013-12-31 |
$0.15 |
2013-09-30 |
$0.13 |
2013-06-30 |
$0.09 |
2013-03-31 |
$0.02 |
2012-12-31 |
$0.01 |
2012-09-30 |
$0.17 |
2012-06-30 |
$0.14 |
2012-03-31 |
$0.14 |
2011-12-31 |
$0.11 |
2011-09-30 |
$0.11 |
2011-06-30 |
$0.18 |
2011-03-31 |
$0.18 |
2010-12-31 |
$0.12 |
2010-09-30 |
$-0.06 |
2010-06-30 |
$0.16 |
2010-03-31 |
$0.13 |
2009-12-31 |
$0.14 |
2009-09-30 |
$0.17 |
2009-06-30 |
$0.17 |
2009-03-31 |
$0.15 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$4.122B |
$1.257B |
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
|